GSK To Pay $60M To Settle Avandia Suits
GlaxoSmithKline PLC has reportedly agreed to pay about $60 million to settle a wave of suits accusing it of suppressing evidence that its diabetes drug Avandia causes heart attacks and strokes....To view the full article, register now.
Already a subscriber? Click here to view full article